By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Tokai Pharmaceuticals 

Boston  Massachusetts    U.S.A.
Phone: Fax:



Company News
Tokai Pharmaceuticals (TKAI) Announces Oral Presentation On Galeterone At The 2016 American Urological Association Annual Meeting 4/26/2016 11:57:03 AM
Tokai Pharmaceuticals (TKAI) Announces Presentations On Galeterone At The AACR Annual Meeting 2016 4/13/2016 11:06:14 AM
Tokai Pharmaceuticals (TKAI) To Present At The 15th Annual Needham Healthcare Conference 4/6/2016 9:16:34 AM
Tokai Pharmaceuticals (TKAI) Announces Dosing Of First Patient In Phase 2 Expansion Study Of Galeterone In Enzalutamide-Refractory mCRPC Patients 3/30/2016 9:39:45 AM
Tokai Pharmaceuticals (TKAI) Strengthens Development Team Through The Addition Of Kelly Lindert, M.D., As Executive Vice President And Head Of Development 3/21/2016 10:24:07 AM
Tokai Pharmaceuticals (TKAI) Reports Full Year 2015 Financial Results 3/10/2016 10:45:33 AM
Tokai Pharmaceuticals (TKAI) Announces Presentation Of New Data Highlighting Unique Galeterone Mechanism At ASCO Genitourinary Cancers Symposium 1/11/2016 12:30:39 PM
Tokai Pharmaceuticals (TKAI) Announces Update On ARMOR3-SV And Expanded Galeterone Clinical Development Program 1/7/2016 12:22:44 PM
Tokai Pharmaceuticals (TKAI) To Present At The Oppenheimer 26th Annual Healthcare Conference 12/2/2015 10:40:42 AM
Tokai Pharmaceuticals (TKAI) Reports Third Quarter 2015 Financial Results 11/10/2015 11:32:58 AM